Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?

about

Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?

Item

http://www.wikidata.org/entity/Q36576316

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Is Abnormal Urine Protein/Osmo ...... Tenofovir Disoproxil Fumarate?

@ast

Is Abnormal Urine Protein/Osmo ...... Tenofovir Disoproxil Fumarate?

@en

type

Item

label

Is Abnormal Urine Protein/Osmo ...... Tenofovir Disoproxil Fumarate?

@ast

Is Abnormal Urine Protein/Osmo ...... Tenofovir Disoproxil Fumarate?

@en

prefLabel

Is Abnormal Urine Protein/Osmo ...... Tenofovir Disoproxil Fumarate?

@ast

Is Abnormal Urine Protein/Osmo ...... Tenofovir Disoproxil Fumarate?

@en

P1476

Is Abnormal Urine Protein/Osmo ...... Tenofovir Disoproxil Fumarate?

@en

P2093

Hatem Amer

http://www.w3.org/2001/XMLSchema#string

Melody L Berg

http://www.w3.org/2001/XMLSchema#string

Nathan W Cummins

http://www.w3.org/2001/XMLSchema#string

Stacey A Rizza

http://www.w3.org/2001/XMLSchema#string

P2860

Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?

Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events

Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.

Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.

Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters

Vitamin D deficiency aggravates nephrotoxicity, hypertension and dyslipidemia caused by tenofovir: role of oxidative stress and renin-angiotensin system.

Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naïve patients with HIV infection.

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

P304

e0149562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0149562

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eugene M Tan

Jasmine Riviere Marcelin

P577

2016-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294256872

http://www.w3.org/2001/XMLSchema#string

P698

26872144

http://www.w3.org/2001/XMLSchema#string

P932

4752319

http://www.w3.org/2001/XMLSchema#string